News

Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...
The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...
Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...
DNA’s chemical cousin, RNA, was the messenger that carries DNA instructions from the double helix in the cell’s nucleus to ...
As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...
Another Massachusetts biotech has reached the end of the road. | Another Massachusetts biotech has reached the end of the ...
In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...
Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...
Rapid precision run-on sequencing (rPRO-seq) may help doctors understand disease states and treatment response in real time.